{
  "tableHeader": {
    "col1Header": "Investigational therapy",
    "col2Header": "Platform",
    "col3Header": "Investigational Indication",
    "col4Header": "Phase"
  },
  "accordions": [
    {
      "accordiontitle": "TAK-700",
      "rowspan": 2,
      "icon": {
        "iconStyleModifier": "xs",
        "iconPath": "../../icons/ico_svg/icons.svg#takui-ico-c-chevron"
      },
      "expandedContent": [
        "[Mechanism of action]",
        "Curabitur lobortis id lorem id bibendum. Ut id"
      ],
      "accordionItems": [
        {
          "title": "Targeted therapy",
          "description": "Chronic Lymphocytic Leukaemia",
          "phase": {
            "title": "Phase 3",
            "stages": [
              {
                "completed": true
              },
              {
                "completed": true
              },
              {
                "completed": true
              }
            ]
          }
        }
      ]
    },
    {
      "accordiontitle": "TAK-924 (Pevonedistat)",
      "rowspan": 4,
      "icon": {
        "iconStyleModifier": "xs",
        "iconPath": "../../icons/ico_svg/icons.svg#takui-ico-c-chevron"
      },
      "expandedContent": [
        "[Mechanism of action]",
        "Curabitur lobortis id lorem id bibendum. Ut id"
      ],
      "accordionItems": [
        {
          "title": "Targeted therapy",
          "description": "Chronic Lymphocytic Leukaemia",
          "phase": {
            "title": "Phase 3",
            "stages": [
              {
                "completed": true
              },
              {
                "completed": true
              },
              {
                "completed": true
              }
            ]
          }
        },
        {
          "title": "Targeted therapy",
          "description": "Low-Blast Acute Myelogenous Leukaemia",
          "phase": {
            "title": "Phase 1/2",
            "stages": [
              {
                "completed": true
              },
              {
                "completed": true
              },
              {
                "completed": false
              }
            ]
          }
        },
        {
          "title": "Targeted therapy",
          "description": "Hidher-risk Myleodysplastic Syndromes",
          "phase": {
            "title": "Phase 3",
            "stages": [
              {
                "completed": true
              },
              {
                "completed": true
              },
              {
                "completed": true
              }
            ]
          }
        }
      ]
    },
    {
      "accordiontitle": "TAK-924 (Pevonedistat)",
      "rowspan": 3,
      "icon": {
        "iconStyleModifier": "xs",
        "iconPath": "../../icons/ico_svg/icons.svg#takui-ico-c-chevron"
      },
      "expandedContent": [
        "[Mechanism of action]",
        "Curabitur lobortis id lorem id bibendum. Ut id"
      ],
      "accordionItems": [
        {
          "title": "Targeted therapy",
          "description": "Low-Blast Acute Myelogenous Leukaemia",
          "phase": {
            "title": "Phase 1/2",
            "stages": [
              {
                "completed": true
              },
              {
                "completed": true
              },
              {
                "completed": false
              }
            ]
          }
        },
        {
          "title": "Targeted therapy",
          "description": "Hidher-risk Myleodysplastic Syndromes",
          "phase": {
            "title": "Phase 3",
            "stages": [
              {
                "completed": true
              },
              {
                "completed": true
              },
              {
                "completed": true
              }
            ]
          }
        }
      ]
    }
  ]
}
